Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Maravai LifeSciences Holdings, Inc. - Class A common stock
(NQ:
MRVI
)
8.435
+0.146 (+1.76%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Aug 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Maravai LifeSciences Holdings, Inc. - Class A common stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 09, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
August 11, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports
August 11, 2025
Today, August 11, 2025, marks a significant day for investors looking beyond the typical S&P 500 giants, as a diverse array of companies across various sectors unveiled their latest quarterly earnings....
Via
MarketMinute
Topics
Economy
Stocks
What to Expect from Maravai LifeSciences's Earnings
↗
August 08, 2025
Via
Benzinga
Earnings Scheduled For August 11, 2025
↗
August 11, 2025
Via
Benzinga
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
July 28, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
July 25, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 22, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 14, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 08, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
June 27, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
June 25, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
June 24, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Insights Ahead: Maravai LifeSciences's Quarterly Earnings
↗
May 09, 2025
Via
Benzinga
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
June 09, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
June 03, 2025
From
TriLink BioTechnologies
Via
Business Wire
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
May 21, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Maravai LifeSciencesReleases 2024 Sustainability Report
May 21, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
May 20, 2025
From
TriLink BioTechnologies
Via
Business Wire
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
May 14, 2025
From
TriLink BioTechnologies
Via
Business Wire
These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results
↗
May 13, 2025
Via
Benzinga
Assessing Maravai LifeSciences: Insights From 5 Financial Analysts
↗
May 13, 2025
Via
Benzinga
Maravai Lifesciences Reports First Quarter 2025 Financial Results
May 12, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 05, 2025
From
The Schall Law Firm
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
May 05, 2025
From
Pomerantz LLP
Via
GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
May 05, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
MRVI Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Investors of Filing Deadline in Class Action Lawsuit
May 01, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
MRVI Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Investors of Filing Deadline in Class Action Lawsuit
May 01, 2025
RADNOR, PA - May 1, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai...
Via
TheNewswire.com
Topics
Lawsuit
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025
May 01, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
